The FDA-Approved Antiviral Raltegravir Inhibits Fascin1-Dependent Invasion of Colorectal Tumor Cells In Vitro and In VivoBegoña Alburquerque-González, Pablo Conesa‐Zamora, Horacio Pérez‐Sánchez et al.|Cancers|2021Cited by 53